NO165542C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.

Info

Publication number
NO165542C
NO165542C NO864306A NO864306A NO165542C NO 165542 C NO165542 C NO 165542C NO 864306 A NO864306 A NO 864306A NO 864306 A NO864306 A NO 864306A NO 165542 C NO165542 C NO 165542C
Authority
NO
Norway
Prior art keywords
thioner
triazol
dialkyl
aryl
preparation
Prior art date
Application number
NO864306A
Other languages
English (en)
Norwegian (no)
Other versions
NO864306D0 (no
NO165542B (no
NO864306L (no
Inventor
John M Kane
Francis P Miller
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO864306D0 publication Critical patent/NO864306D0/no
Publication of NO864306L publication Critical patent/NO864306L/no
Publication of NO165542B publication Critical patent/NO165542B/no
Publication of NO165542C publication Critical patent/NO165542C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO864306A 1985-10-29 1986-10-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner. NO165542C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79235985A 1985-10-29 1985-10-29
US80761385A 1985-12-11 1985-12-11

Publications (4)

Publication Number Publication Date
NO864306D0 NO864306D0 (no) 1986-10-28
NO864306L NO864306L (no) 1987-04-30
NO165542B NO165542B (no) 1990-11-19
NO165542C true NO165542C (no) 1991-02-27

Family

ID=27121269

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864306A NO165542C (no) 1985-10-29 1986-10-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.

Country Status (19)

Country Link
EP (1) EP0221485B1 (pt)
JP (1) JPH07116162B2 (pt)
KR (1) KR900003879B1 (pt)
CN (1) CN1014993B (pt)
AR (1) AR243171A1 (pt)
AU (1) AU587646B2 (pt)
CA (2) CA1284997C (pt)
DE (1) DE3676632D1 (pt)
DK (1) DK164785C (pt)
ES (1) ES2031449T3 (pt)
FI (1) FI89047C (pt)
GR (1) GR3001246T3 (pt)
HU (1) HU196191B (pt)
IE (1) IE58969B1 (pt)
IL (1) IL80434A (pt)
NO (1) NO165542C (pt)
NZ (1) NZ218087A (pt)
PH (2) PH22377A (pt)
PT (1) PT83636B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR243169A1 (es) * 1985-10-29 1993-07-30 Merrell Pharma Inc Procedimiento para preparar 5-naftil-2,4-dialquil-3h-1,2,4-triazol-3-tionas.
JP2593084B2 (ja) * 1986-12-19 1997-03-19 メレルダウファーマスーティカルズ インコーポレーテッド 5−アリールー3h−1,2,4−トリアゾールー3−オン類の神経変性障害の処置への用途
JP2542880B2 (ja) * 1986-12-19 1996-10-09 メレルダウファーマスーティカルズ インコーポレーテッド 5−アリ―ル−3h−1,2,4,−トリアゾ―ル−3−オン類の抗痙攣剤としての用途
EP0280867A1 (en) * 1987-01-27 1988-09-07 Merrell Dow Pharmaceuticals Inc. Process for the preparation of 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones
US4847276A (en) * 1988-09-06 1989-07-11 Merrell Dow Pharmaceuticals Inc. Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione
AU679130B2 (en) * 1993-10-29 1997-06-19 Aventis Inc. 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles useful as memory enhancers
CA2193800C (en) * 1994-07-07 1999-03-16 Sandra K. Stolz-Dunn Process for the preparation of 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR243169A1 (es) * 1985-10-29 1993-07-30 Merrell Pharma Inc Procedimiento para preparar 5-naftil-2,4-dialquil-3h-1,2,4-triazol-3-tionas.
DK570987A (da) * 1986-12-01 1988-06-02 Hoffmann La Roche Oxadiazol-, thiadiazol- og triazolforbindelser

Also Published As

Publication number Publication date
DK164785C (da) 1992-12-28
IE862832L (en) 1987-04-29
JPS62106085A (ja) 1987-05-16
EP0221485B1 (en) 1990-12-27
PT83636A (en) 1986-11-01
NO864306D0 (no) 1986-10-28
NZ218087A (en) 1989-05-29
CA1301655C (en) 1992-05-26
CN86106880A (zh) 1987-06-10
DK514886A (da) 1987-04-30
DK514886D0 (da) 1986-10-28
NO165542B (no) 1990-11-19
IL80434A0 (en) 1987-01-30
FI89047C (fi) 1993-08-10
PH22377A (en) 1988-08-12
JPH07116162B2 (ja) 1995-12-13
IL80434A (en) 1991-01-31
AU6438686A (en) 1987-04-30
FI864377A0 (fi) 1986-10-28
HU196191B (en) 1988-10-28
PH23275A (en) 1989-06-23
IE58969B1 (en) 1993-12-01
CN1014993B (zh) 1991-12-04
AU587646B2 (en) 1989-08-24
KR900003879B1 (ko) 1990-06-04
CA1284997C (en) 1991-06-18
FI89047B (fi) 1993-04-30
DE3676632D1 (de) 1991-02-07
AR243171A1 (es) 1993-07-30
FI864377A (fi) 1987-04-30
ES2031449T3 (es) 1992-12-16
PT83636B (pt) 1988-10-14
GR3001246T3 (en) 1992-07-30
KR870004006A (ko) 1987-05-06
DK164785B (da) 1992-08-17
HUT45030A (en) 1988-05-30
NO864306L (no) 1987-04-30
EP0221485A1 (en) 1987-05-13

Similar Documents

Publication Publication Date Title
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO873680L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
NO164972C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner.
NO166642C (no) Anaolgifremgangsmaate for fremstilling av terapeutisk aktive 3-aryl-5-alkylthio-4h-1,2,4-triazoler.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2001